C16H14O2
238.28 g/mol
Pharmaceutical IntermediateWarning
6-methyl-4-phenyl-3,4-dihydrochromen-2-one
CAS40546-94-9EC609-846-0
Category
Pharmaceutical Intermediate
Compound Class
Heterocycle
Primary Use
Pharmaceutical Intermediate
This compound is a dihydrochromenone derivative that serves as a pharmaceutical intermediate. It is a chemical building block used in the manufacturing of active pharmaceutical ingredients.
pharmaceutical intermediate for API manufacturinglaboratory research compound
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing 6-methyl-4-phenyl-3,4-dihydrochromen-2-one?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Related Compounds
ReferenceSame Category
Ethyl 4-methyl-2-pyrrolecarboxylate
CAS40611-85-6
pharmaceutical intermediate
ReferenceSame Category
5'-O-Dimethoxytrityl-deoxythymidine
CAS40615-39-2
pharmaceutical intermediate
ReferenceSame Category
1,7-Dichloroheptan-4-one
CAS40624-07-5
pharmaceutical intermediate
ReferenceSame Category
2-Acetoxy-2-methylpropionyl bromide
CAS40635-67-4
pharmaceutical intermediate
Referencesame scaffold
6-Carboxyl-4-phenyl-3,4-dihydrocoumarin
CAS356782-33-7
pharmaceutical intermediate
Referencesame scaffold
Methyl 2-oxo-4-phenyl-3,4-dihydro-2H-1-benzopyran-6-carboxylate
CAS380636-42-0
pharmaceutical intermediate
Safety Reference
Warning
H317May cause an allergic skin reaction
H412Harmful to aquatic life with long lasting effects
Identifiers
IUPAC Name
6-methyl-4-phenyl-3,4-dihydrochromen-2-one
InChIKey
SUHIZPDCJOQZLN-UHFFFAOYSA-N
SMILES
CC1=CC2=C(C=C1)OC(=O)CC2C3=CC=CC=C3
Synonyms (15)
- 6-Methyl-4-Phenylchromanone
- Tolterodine Impurity 1
- Tolterodine Lactone Impurity
Sourcing 6-methyl-4-phenyl-3,4-dihydrochromen-2-one?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.